Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM)

PHASE3CompletedINTERVENTIONAL

Timeline

Start Date

March 31, 1995

Study Completion Date

September 30, 2002

Conditions

ArrhythmiaAtrial FibrillationCardiovascular DiseasesHeart Diseases

Interventions

DRUG

amiodarone

DRUG

sotalol

DRUG

propafenone

DRUG

flecainide

DRUG

quinidine

DRUG

moricizine

DRUG

disopyramide

DRUG

procainamide

DRUG

adrenergic beta antagonists

DRUG

verapamil

DRUG

diltiazem

DRUG

digoxin

PROCEDURE

catheter ablation

DEVICE

pacemaker, artificial

All Listed Sponsors

lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00000556 - Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) | Biotech Hunter | Biotech Hunter